False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.
Identifieur interne : 002535 ( PubMed/Curation ); précédent : 002534; suivant : 002536False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.
Auteurs : Kuo-Chien Tsao [Taïwan] ; Guang-Wu Chen ; Chung-Guei Huang ; Ya-Ling Huang ; Jing-Yi Lin ; Chee-Keng Mok ; Mok-Chee Keng ; Chien-Fen Sun ; Shin-Ru ShihSource :
- Journal of medical virology [ 0146-6615 ] ; 2005.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Anticorps antiviraux (sang), Antigènes de deltarétrovirus (immunologie), Enfant, Faux positifs, Femelle, Humains, Infections à HTLV-I (immunologie), Infections à HTLV-I (virologie), Infections à HTLV-II (immunologie), Infections à HTLV-II (virologie), Mâle, Réactions croisées, Sujet âgé, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (immunologie), Tests de neutralisation, Virus du SRAS (immunologie).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- immunologie : Antigènes de deltarétrovirus, Infections à HTLV-I, Infections à HTLV-II, Syndrome respiratoire aigu sévère, Virus du SRAS.
- sang : Anticorps antiviraux.
- virologie : Infections à HTLV-I, Infections à HTLV-II.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Faux positifs, Femelle, Humains, Mâle, Réactions croisées, Sujet âgé, Tests de neutralisation.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Antibodies, Viral (blood), Child, Cross Reactions, Deltaretrovirus Antigens (immunology), False Positive Reactions, Female, HTLV-I Infections (immunology), HTLV-I Infections (virology), HTLV-II Infections (immunology), HTLV-II Infections (virology), Humans, Male, Middle Aged, Neutralization Tests, SARS Virus (immunology), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (immunology).
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Deltaretrovirus Antigens.
- diagnosis : Severe Acute Respiratory Syndrome.
- immunology : HTLV-I Infections, HTLV-II Infections, SARS Virus, Severe Acute Respiratory Syndrome.
- virology : HTLV-I Infections, HTLV-II Infections.
- Adolescent, Adult, Aged, Child, Cross Reactions, False Positive Reactions, Female, Humans, Male, Middle Aged, Neutralization Tests.
Abstract
Taiwan suffered from the outbreak of severe acute respiratory syndrome (SARS) in 2003. Our laboratory performed a series of virology and serology tests for SARS patients admitted to our hospital. Cross-reactivity was found when testing for antibody against human T-cell lymphotropic virus (HTLV) in one patient with SARS. Therefore, antibodies against HTLV were examined in paired-sera from 26 SARS patients. ELISA and a neutralization test were used to measure anti-SARS antibodies. Seroconversion for antibody against SARS-CoV was observed in all patients. Surprisingly, with the use of ELISA for HTLV, sera for 13 patients were positive for HTLV (50%), and seroconversion for HTLV was also observed in 10 patients (38.5%). Western blot for HTLV on those 26 paired-sera from 13 HTLV-positive patients displayed 5 positive results for HTLV-I, 7 positive results for HTLV-II, 1 positive result for both HTLV-I and II, 9 negative results for either HTLV-I or HTLV-II, and 4 "indeterminate" results. The findings that antibody to HTLV can be detected in blood samples collected from SARS patients provide important information for safe handling of blood products. Without such knowledge, blood products can be discarded mistakenly even though they contain anti-SARS-CoV antibodies that may be potentially valuable for SARS therapy.
DOI: 10.1002/jmv.20460
PubMed: 16173022
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002535
Links to Exploration step
pubmed:16173022Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.</title><author><name sortKey="Tsao, Kuo Chien" sort="Tsao, Kuo Chien" uniqKey="Tsao K" first="Kuo-Chien" last="Tsao">Kuo-Chien Tsao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pathology, Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Clinical Pathology, Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-Yuan</wicri:regionArea></affiliation></author><author><name sortKey="Chen, Guang Wu" sort="Chen, Guang Wu" uniqKey="Chen G" first="Guang-Wu" last="Chen">Guang-Wu Chen</name></author><author><name sortKey="Huang, Chung Guei" sort="Huang, Chung Guei" uniqKey="Huang C" first="Chung-Guei" last="Huang">Chung-Guei Huang</name></author><author><name sortKey="Huang, Ya Ling" sort="Huang, Ya Ling" uniqKey="Huang Y" first="Ya-Ling" last="Huang">Ya-Ling Huang</name></author><author><name sortKey="Lin, Jing Yi" sort="Lin, Jing Yi" uniqKey="Lin J" first="Jing-Yi" last="Lin">Jing-Yi Lin</name></author><author><name sortKey="Mok, Chee Keng" sort="Mok, Chee Keng" uniqKey="Mok C" first="Chee-Keng" last="Mok">Chee-Keng Mok</name></author><author><name sortKey="Keng, Mok Chee" sort="Keng, Mok Chee" uniqKey="Keng M" first="Mok-Chee" last="Keng">Mok-Chee Keng</name></author><author><name sortKey="Sun, Chien Fen" sort="Sun, Chien Fen" uniqKey="Sun C" first="Chien-Fen" last="Sun">Chien-Fen Sun</name></author><author><name sortKey="Shih, Shin Ru" sort="Shih, Shin Ru" uniqKey="Shih S" first="Shin-Ru" last="Shih">Shin-Ru Shih</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16173022</idno><idno type="pmid">16173022</idno><idno type="doi">10.1002/jmv.20460</idno><idno type="wicri:Area/PubMed/Corpus">002535</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002535</idno><idno type="wicri:Area/PubMed/Curation">002535</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002535</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.</title><author><name sortKey="Tsao, Kuo Chien" sort="Tsao, Kuo Chien" uniqKey="Tsao K" first="Kuo-Chien" last="Tsao">Kuo-Chien Tsao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pathology, Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Clinical Pathology, Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-Yuan</wicri:regionArea></affiliation></author><author><name sortKey="Chen, Guang Wu" sort="Chen, Guang Wu" uniqKey="Chen G" first="Guang-Wu" last="Chen">Guang-Wu Chen</name></author><author><name sortKey="Huang, Chung Guei" sort="Huang, Chung Guei" uniqKey="Huang C" first="Chung-Guei" last="Huang">Chung-Guei Huang</name></author><author><name sortKey="Huang, Ya Ling" sort="Huang, Ya Ling" uniqKey="Huang Y" first="Ya-Ling" last="Huang">Ya-Ling Huang</name></author><author><name sortKey="Lin, Jing Yi" sort="Lin, Jing Yi" uniqKey="Lin J" first="Jing-Yi" last="Lin">Jing-Yi Lin</name></author><author><name sortKey="Mok, Chee Keng" sort="Mok, Chee Keng" uniqKey="Mok C" first="Chee-Keng" last="Mok">Chee-Keng Mok</name></author><author><name sortKey="Keng, Mok Chee" sort="Keng, Mok Chee" uniqKey="Keng M" first="Mok-Chee" last="Keng">Mok-Chee Keng</name></author><author><name sortKey="Sun, Chien Fen" sort="Sun, Chien Fen" uniqKey="Sun C" first="Chien-Fen" last="Sun">Chien-Fen Sun</name></author><author><name sortKey="Shih, Shin Ru" sort="Shih, Shin Ru" uniqKey="Shih S" first="Shin-Ru" last="Shih">Shin-Ru Shih</name></author></analytic><series><title level="j">Journal of medical virology</title><idno type="ISSN">0146-6615</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Antibodies, Viral (blood)</term><term>Child</term><term>Cross Reactions</term><term>Deltaretrovirus Antigens (immunology)</term><term>False Positive Reactions</term><term>Female</term><term>HTLV-I Infections (immunology)</term><term>HTLV-I Infections (virology)</term><term>HTLV-II Infections (immunology)</term><term>HTLV-II Infections (virology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neutralization Tests</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antiviraux (sang)</term><term>Antigènes de deltarétrovirus (immunologie)</term><term>Enfant</term><term>Faux positifs</term><term>Femelle</term><term>Humains</term><term>Infections à HTLV-I (immunologie)</term><term>Infections à HTLV-I (virologie)</term><term>Infections à HTLV-II (immunologie)</term><term>Infections à HTLV-II (virologie)</term><term>Mâle</term><term>Réactions croisées</term><term>Sujet âgé</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Tests de neutralisation</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Deltaretrovirus Antigens</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes de deltarétrovirus</term><term>Infections à HTLV-I</term><term>Infections à HTLV-II</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HTLV-I Infections</term><term>HTLV-II Infections</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à HTLV-I</term><term>Infections à HTLV-II</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HTLV-I Infections</term><term>HTLV-II Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Child</term><term>Cross Reactions</term><term>False Positive Reactions</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neutralization Tests</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enfant</term><term>Faux positifs</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Réactions croisées</term><term>Sujet âgé</term><term>Tests de neutralisation</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Taiwan suffered from the outbreak of severe acute respiratory syndrome (SARS) in 2003. Our laboratory performed a series of virology and serology tests for SARS patients admitted to our hospital. Cross-reactivity was found when testing for antibody against human T-cell lymphotropic virus (HTLV) in one patient with SARS. Therefore, antibodies against HTLV were examined in paired-sera from 26 SARS patients. ELISA and a neutralization test were used to measure anti-SARS antibodies. Seroconversion for antibody against SARS-CoV was observed in all patients. Surprisingly, with the use of ELISA for HTLV, sera for 13 patients were positive for HTLV (50%), and seroconversion for HTLV was also observed in 10 patients (38.5%). Western blot for HTLV on those 26 paired-sera from 13 HTLV-positive patients displayed 5 positive results for HTLV-I, 7 positive results for HTLV-II, 1 positive result for both HTLV-I and II, 9 negative results for either HTLV-I or HTLV-II, and 4 "indeterminate" results. The findings that antibody to HTLV can be detected in blood samples collected from SARS patients provide important information for safe handling of blood products. Without such knowledge, blood products can be discarded mistakenly even though they contain anti-SARS-CoV antibodies that may be potentially valuable for SARS therapy.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16173022</PMID><DateCompleted><Year>2005</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0146-6615</ISSN><JournalIssue CitedMedium="Print"><Volume>77</Volume><Issue>3</Issue><PubDate><Year>2005</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J. Med. Virol.</ISOAbbreviation></Journal><ArticleTitle>False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.</ArticleTitle><Pagination><MedlinePgn>331-6</MedlinePgn></Pagination><Abstract><AbstractText>Taiwan suffered from the outbreak of severe acute respiratory syndrome (SARS) in 2003. Our laboratory performed a series of virology and serology tests for SARS patients admitted to our hospital. Cross-reactivity was found when testing for antibody against human T-cell lymphotropic virus (HTLV) in one patient with SARS. Therefore, antibodies against HTLV were examined in paired-sera from 26 SARS patients. ELISA and a neutralization test were used to measure anti-SARS antibodies. Seroconversion for antibody against SARS-CoV was observed in all patients. Surprisingly, with the use of ELISA for HTLV, sera for 13 patients were positive for HTLV (50%), and seroconversion for HTLV was also observed in 10 patients (38.5%). Western blot for HTLV on those 26 paired-sera from 13 HTLV-positive patients displayed 5 positive results for HTLV-I, 7 positive results for HTLV-II, 1 positive result for both HTLV-I and II, 9 negative results for either HTLV-I or HTLV-II, and 4 "indeterminate" results. The findings that antibody to HTLV can be detected in blood samples collected from SARS patients provide important information for safe handling of blood products. Without such knowledge, blood products can be discarded mistakenly even though they contain anti-SARS-CoV antibodies that may be potentially valuable for SARS therapy.</AbstractText><CopyrightInformation>(c) 2005 Wiley-Liss, inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Kuo-Chien</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, Clinical Virology Laboratory, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guang-Wu</ForeName><Initials>GW</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Guei</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ya-Ling</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jing-Yi</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Mok</LastName><ForeName>Chee-Keng</ForeName><Initials>CK</Initials></Author><Author ValidYN="N"><LastName>Keng</LastName><ForeName>Mok-Chee</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Chien-Fen</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015485">Deltaretrovirus Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Med Virol. 2006 Jan;78(1):139</RefSource><Note>Keng, Mok-Chee [corrected to Mok, Chee-Keng]</Note></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015485" MajorTopicYN="N">Deltaretrovirus Antigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005189" MajorTopicYN="N">False Positive Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015490" MajorTopicYN="N">HTLV-I Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015491" MajorTopicYN="N">HTLV-II Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>9</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>11</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>9</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16173022</ArticleId><ArticleId IdType="doi">10.1002/jmv.20460</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002535 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002535 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:16173022
|texte= False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16173022" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |